Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma.
Khushman M, Prodduturvar P, Mneimneh W, Zotto VD, Akbar S, Grimm L, Rider P, Hunter J, Alkharabsheh O, Patel GK, Fabregas JC, Singh AP. Khushman M, et al. Among authors: fabregas jc. Oncotarget. 2021 Jul 20;12(15):1490-1498. doi: 10.18632/oncotarget.28025. eCollection 2021 Jul 20. Oncotarget. 2021. PMID: 34316329 Free PMC article.
Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.
Altshuler E, Richhart R, King W, Aryan M, Mathavan A, Mathavan A, Hones K, Leach DF 3rd, Pucci L, Riklan J, Haley P, Sahin I, Ramnaraign B, Rogers S, Nassour I, Hughes S, George TJ, Fabregas J. Altshuler E, et al. Oncotarget. 2023 Apr 15;14:351-357. doi: 10.18632/oncotarget.28406. Oncotarget. 2023. PMID: 37068159 Free PMC article.
Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.
Altshuler E, Richhart R, King W, Aryan M, Mathavan A, Mathavan A, Hones K, Leach DF 3rd, Pucci L, Riklan J, Haley P, Sahin I, Ramnaraign B, Rogers S, Nassour I, Hughes S, George TJ, Fabregas J. Altshuler E, et al. Oncotarget. 2023 Dec 12;14:971. doi: 10.18632/oncotarget.28491. Oncotarget. 2023. PMID: 38085073 Free PMC article. No abstract available.
Clinical Updates for Colon Cancer Care in 2022.
Fabregas JC, Ramnaraign B, George TJ. Fabregas JC, et al. Clin Colorectal Cancer. 2022 Sep;21(3):198-203. doi: 10.1016/j.clcc.2022.05.006. Epub 2022 Jun 3. Clin Colorectal Cancer. 2022. PMID: 35729033 Review.
Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis.
Ozer M, Goksu SY, Lin RY, Ayasun R, Kahramangil D, Rogers SC, Fabregas JC, Ramnaraign BH, George TJ, Feely M, Cabrera R, Duarte S, Zarrinpar A, Sahin I. Ozer M, et al. Among authors: fabregas jc. J Hepatocell Carcinoma. 2023 Jul 19;10:1129-1141. doi: 10.2147/JHC.S417273. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37489126 Free PMC article.
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
Evens AM, Kanakry JA, Sehn LH, Kritharis A, Feldman T, Kroll A, Gascoyne RD, Abramson JS, Petrich AM, Hernandez-Ilizaliturri FJ, Al-Mansour Z, Adeimy C, Hemminger J, Bartlett NL, Mato A, Caimi PF, Advani RH, Klein AK, Nabhan C, Smith SM, Fabregas JC, Lossos IS, Press OW, Fenske TS, Friedberg JW, Vose JM, Blum KA. Evens AM, et al. Among authors: fabregas jc. Am J Hematol. 2015 Sep;90(9):778-83. doi: 10.1002/ajh.24082. Am J Hematol. 2015. PMID: 26044261 Free article.
19 results